International Survey to Establish Prioritized Outcomes for Trials in People With Coronavirus Disease 2019.

ABSTRACT:

Objectives

There are over 4,000 trials conducted in people with coronavirus disease 2019. However, the variability of outcomes and the omission of patient-centered outcomes may diminish the impact of these trials on decision-making. The aim of this study was to generate a consensus-based, prioritized list of outcomes for coronavirus disease 2019 trials.

Design

In an online survey conducted in English, Chinese, Italian, Portuguese, and Spanish languages, adults with coronavirus disease 2019, their family members, health professionals, and the general public rated the importance of outcomes using a 9-point Likert scale (7-9, critical importance) and completed a Best-Worst Scale to estimate relative importance. Participant comments were analyzed thematically.

Setting

Int

SUBMITTER: Evangelidis N 

PROVIDER: S-EPMC7448718 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature